##plugins.themes.academic_pro.article.sidebar##
Published
Oct 25, 2024
Download
Statistic
Read Counter : 21
Download : 6
Main Article Content
Abstract
The widespread implementation of invasive procedures such as coronary angiography and primary percutaneous coronary intervention (PCI) into the routine management of patients with acute ST-segment elevation myocardial infarction (STEMI) in the last 10 years has led to a significant improvement in patient prognosis. At the same time, this also raises new problems and questions, mostly related to the fact that there are many elderly patients and/or patients with comorbidities who need to undergo this invasive procedure. One of the most important comorbidities is renal insufficiency. STEMI patients with renal insufficiency typically present with more extensive atherosclerotic lesions, including diffuse coronary calcification, which poses a challenge to the interventional cardiologist due to a higher risk of periprocedural complications, higher risk of restenosis, major adverse cardiovascular event (MACE) , and patient mortality. This review discusses in depth the influence of renal insufficiency on MACE and mortality in STEMI patients.
Keywords: renal insufficiency, STEMI, MACE, mortality.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Nurudinulloh, A. I., & Anjarwani, S. (2024). In-Depth Review of the Influence of Renal Insuficiency on Major Adverse Cardiovascular Event (MACE) and Mortality in Patients with Acute St-Segment Elevation Myocardial In- farction (STEMI). Jurnal Klinik Dan Riset Kesehatan, 4(1), 46-58. https://doi.org/10.11594/jk-risk.04.1.6
References
1. Antman E, Bassand JP, Klein W, Ohman M, Lopez Sendon JL, Rydén L, et al. Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee f or the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–69.
2. Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, et al. Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction [Internet]. Available from: http://jama.jamanetwork.com/
3. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Vol. 13, European Heart Journal: Acute Cardiovascular Care. Oxford University Press; 2024. p. 55–161.
4. Indrawati L, Tjandrarini DH. Peran Indikator Pelayanan Kesehatan untuk Meningkatkan Nilai Sub Indeks Kesehatan Reproduksi dalam Indeks Pembangunan Kesehatan Masyarakat (IPKM). Media Penelitian dan Pengembangan Kesehatan. 2018 Oct 17;28(2):95–102.
5. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study. Journal of the American Society of Nephrology. 2003 Dec;14(12):3233–8.
6. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002 Aug 20;106(8):974–80.
7. Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002 Apr 3;39(7):1113–9.
8. Keith DS, Nichols GA, Gullion CM, Betz Brown J, Smith DH. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization [Internet]. Available from: http://archinte.jamanetwork.com/
9. Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM. Differential symptoms of acute myocardial infarction in patients with kidney disease: A community-wide perspective. American Journal of Kidney Diseases. 2006 Mar;47(3):378–84.
10. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, Mcclellan MB. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients Background: Patients with end-stage renal disease are known [Internet]. 2002. Available from: www.annals.org
11. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, et al. Pathophysiology of Atherosclerosis: The Role of Inflammation. Vol. 17, Current Pharmaceutical Design. 2011.
12. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrology Dialysis Transplantation. 2003 Sep 1;18(9):1731–40.
13. Herzog CA. How to manage the renal patient with coronary heart disease: The agony and the ecstasy of opinion-based medicine. Vol. 14, Journal of the American Society of Nephrology. 2003. p. 2556–72.
14. Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: A collaborative project of the United States renal data system and the national registry of myocardial infarction. Circulation. 2007 Oct;116(13):1465–72.
15. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. The lancet. 2003 Jan 4;361(9351):13-20.
16. Inrig JK, Patel UD, Briley LP, She L, Gillespie BS, Easton JD, et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrology Dialysis Transplantation. 2008 Mar;23(3):934–40.
17. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Vol. 44, American Journal of Kidney Diseases. 2004. p. 12–24.
18. McCullough PA. Contrast-Induced Acute Kidney Injury. Vol. 51, Journal of the American College of Cardiology. Elsevier USA; 2008. p. 1419–28.
19. Weisbord SD, Hartwig KC, Sonel AF, Fine MJ, Palevsky P. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheterization and Cardiovascular Interventions. 2008 Jun 1;71(7):879–85.
20. Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D, et al. The Reno-Protective Effect of Hydration With Sodium Bicarbonate Plus N-Acetylcysteine in Patients Undergoing Emergency Percutaneous Coronary Intervention. The RENO Study. J Am Coll Cardiol. 2007 Mar 27;49(12):1283–8.
21. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of Contrast Media-Associated Nephropathy Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty [Internet]. Available from: http://archinte.jamanetwork.com/
22. Scheller B, Hennen B, Pohl A, Schieffer H, Markwirth T. Acute and subacute stent occlusion: Risk-reduction by ionic contrast media. Eur Heart J. 2001;22(5):385–91.
23. Hubbard CR, Blankenship JC, Scott TD, Skelding KA, Berger PB. Emergency Pretreatment for Contrast Allergy Before Direct Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. American Journal of Cardiology. 2008 Dec 1;102(11):1469–72.
24. Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014 Oct 1;16(11):1655–73.
25. Ginsberg F, Parrillo JE. Cardiogenic Shock: A Historical Perspective. Vol. 25, Critical Care Clinics. 2009. p. 103–14.
26. Degeare VS, Boura JA, Grines LL, O’neill WW, Grines CL. Predictive Value of the Killip Classification in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
27. Sulo G, Igland J, Vollset SE, Nygård O, Ebbing M, Sulo E, et al. Heart failure complicating acute myocardial infarction; burden and timing of occurrence: A nation-wide analysis including 86 771 patients from the cardiovascular disease in norway (CVDNOR) project. J Am Heart Assoc. 2016 Jan 1;5(1):1–8.
28. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(7):2064–89.
29. Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, et al. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv. 2013 Apr;6(2):176–83.
30. Widimsky P, Rychlik I. Renal disease and acute coronary syndrome. Vol. 96, Heart. 2010. p. 86–92.
2. Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, et al. Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction [Internet]. Available from: http://jama.jamanetwork.com/
3. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Vol. 13, European Heart Journal: Acute Cardiovascular Care. Oxford University Press; 2024. p. 55–161.
4. Indrawati L, Tjandrarini DH. Peran Indikator Pelayanan Kesehatan untuk Meningkatkan Nilai Sub Indeks Kesehatan Reproduksi dalam Indeks Pembangunan Kesehatan Masyarakat (IPKM). Media Penelitian dan Pengembangan Kesehatan. 2018 Oct 17;28(2):95–102.
5. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between Renal Insufficiency and Inducible Ischemia in Patients with Coronary Artery Disease: The Heart and Soul Study. Journal of the American Society of Nephrology. 2003 Dec;14(12):3233–8.
6. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002 Aug 20;106(8):974–80.
7. Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002 Apr 3;39(7):1113–9.
8. Keith DS, Nichols GA, Gullion CM, Betz Brown J, Smith DH. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization [Internet]. Available from: http://archinte.jamanetwork.com/
9. Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM. Differential symptoms of acute myocardial infarction in patients with kidney disease: A community-wide perspective. American Journal of Kidney Diseases. 2006 Mar;47(3):378–84.
10. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, Mcclellan MB. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients Background: Patients with end-stage renal disease are known [Internet]. 2002. Available from: www.annals.org
11. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K, et al. Pathophysiology of Atherosclerosis: The Role of Inflammation. Vol. 17, Current Pharmaceutical Design. 2011.
12. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrology Dialysis Transplantation. 2003 Sep 1;18(9):1731–40.
13. Herzog CA. How to manage the renal patient with coronary heart disease: The agony and the ecstasy of opinion-based medicine. Vol. 14, Journal of the American Society of Nephrology. 2003. p. 2556–72.
14. Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: A collaborative project of the United States renal data system and the national registry of myocardial infarction. Circulation. 2007 Oct;116(13):1465–72.
15. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. The lancet. 2003 Jan 4;361(9351):13-20.
16. Inrig JK, Patel UD, Briley LP, She L, Gillespie BS, Easton JD, et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrology Dialysis Transplantation. 2008 Mar;23(3):934–40.
17. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Vol. 44, American Journal of Kidney Diseases. 2004. p. 12–24.
18. McCullough PA. Contrast-Induced Acute Kidney Injury. Vol. 51, Journal of the American College of Cardiology. Elsevier USA; 2008. p. 1419–28.
19. Weisbord SD, Hartwig KC, Sonel AF, Fine MJ, Palevsky P. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheterization and Cardiovascular Interventions. 2008 Jun 1;71(7):879–85.
20. Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D, et al. The Reno-Protective Effect of Hydration With Sodium Bicarbonate Plus N-Acetylcysteine in Patients Undergoing Emergency Percutaneous Coronary Intervention. The RENO Study. J Am Coll Cardiol. 2007 Mar 27;49(12):1283–8.
21. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of Contrast Media-Associated Nephropathy Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty [Internet]. Available from: http://archinte.jamanetwork.com/
22. Scheller B, Hennen B, Pohl A, Schieffer H, Markwirth T. Acute and subacute stent occlusion: Risk-reduction by ionic contrast media. Eur Heart J. 2001;22(5):385–91.
23. Hubbard CR, Blankenship JC, Scott TD, Skelding KA, Berger PB. Emergency Pretreatment for Contrast Allergy Before Direct Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. American Journal of Cardiology. 2008 Dec 1;102(11):1469–72.
24. Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014 Oct 1;16(11):1655–73.
25. Ginsberg F, Parrillo JE. Cardiogenic Shock: A Historical Perspective. Vol. 25, Critical Care Clinics. 2009. p. 103–14.
26. Degeare VS, Boura JA, Grines LL, O’neill WW, Grines CL. Predictive Value of the Killip Classification in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
27. Sulo G, Igland J, Vollset SE, Nygård O, Ebbing M, Sulo E, et al. Heart failure complicating acute myocardial infarction; burden and timing of occurrence: A nation-wide analysis including 86 771 patients from the cardiovascular disease in norway (CVDNOR) project. J Am Heart Assoc. 2016 Jan 1;5(1):1–8.
28. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2013;44(7):2064–89.
29. Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, et al. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction timing, characteristics, and clinical outcomes. Circ Cardiovasc Interv. 2013 Apr;6(2):176–83.
30. Widimsky P, Rychlik I. Renal disease and acute coronary syndrome. Vol. 96, Heart. 2010. p. 86–92.